Bathi operasional sadurunge amortisasi: veracyte.com (VCYT)

Logo perusahaan publik Veracyte (VCYT)

High service margins and FCF growth at Veracyte, Inc. (VCYT) ensure stability, as evidenced by the operating profit history in cash terms, where 112.64 is recorded as the baseline value. The development of AI algorithms and the expansion of Afirma with Decipher stimulate growth. An impeccable reputation in molecular diagnostics and the trust of oncologists solidify its status as a scientific leader saving patients' lives.

VCYT Veracyte Diagnostics: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 10.11.2026

Ringkesan rincian data analitis Veracyte (VCYT)

- rega pasar lan target rega analis:
Rega saham Veracyte Diagnostics|VCYT - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Veracyte|VCYT - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Veracyte|VCYT - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku veracyte.com|VCYT - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Veracyte, Inc.|VCYT - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Veracyte Inc|VCYT - Gunggung utang perusahaan|Utang-utang marang aset resik Veracyte|VCYT - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Veracyte|Likuiditas cepet veracyte.com
- data bathi bisnis lan rasio investasi:
VCYT - Bathi resik|Bathi resik sing dikarepake Veracyte, Inc.|VCYT - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi veracyte.com|VCYT - Pangali PEG|Pangali EV/EBITDA Veracyte|VCYT - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Veracyte|VCYT - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan veracyte.com|VCYT - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Veracyte, Inc.
Ringkesan analitik perusahaan:VCYT Veracyte Diagnostics
Produk asil prodhuksi Veracyte Corp

An investment audit of Veracyte, Inc. (VCYT) requires an analysis of daily cash returns from core operations, excluding non-recurring financial effects. This indicator captures the net daily cash flow from sales, allowing the company's total operating profit to track the scaling efficiency of its cloud database and the expansion of its diagnostic tests. A declining curve signals a slowdown in market monopolization, warning of the risk of purchasing an overvalued asset.

Pesaing Veracyte, Inc. (VCYT)

Bathi operasional EBITDA Caris Corp CAI|GH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CELC (celcuity.com) - Bathi operasional sadurunge amortisasi|GRAL: Bathi operasional EBITDA|Myriad Genetics Inc (MYGN) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Castle Biosciences Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BNR|Bathi operasional sadurunge ngurangi amortisasi VNRX (VolitionRx Limited)|BDSX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Precipio PRPO|Pendapatan operasional sadurunge ngurangi amortisasi Check-Cap Ltd (CHEK)|Mainz Biomed - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi OncoCyte Inc OCX